All Stories

  1. Antidiabetic and Antioxidant Potential of Sapindus trifoliatus in Alloxan-induced Diabetic Rats via PI3K/AKT Pathway Activation
  2. Advances in Ciprofloxacin Derivatives: Emerging Strategies to Combat Antimicrobial Resistance
  3. Pharmacological and comparative evaluation of green coffee bean extract (Coffee arabica) and phytoconstituents for the attenuating airway inflammation via NF-κB inhibitory signaling pathway in ovalbumin-induced Balb/c
  4. Anticandidal Effects of Ocimum basilicum and Ocimum sanctum: Unveiling in vitro and in vivo Efficacy against Systemic Candidiasis
  5. Nanomedicine-enabled neuroprotection: therapeutic role of berberine in neurodegenerative diseases
  6. The Dual Identity of Laurus nobilis L.: A Culinary Delight and Pharmacological Treasure
  7. Icariin as a therapeutic agent in breast cancer: modulating apoptosis and suppressing proliferation
  8. Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration
  9. Enhancing drug bioavailability for Parkinson's disease: The promise of chitosan delivery mechanisms
  10. Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancer
  11. Harnessing the FOXO-SIRT1 axis: insights into cellular stress, metabolism, and aging
  12. From Plants to Therapies: Exploring the Pharmacology of Coumestrol for Neurological Conditions
  13. Epithelial–mesenchymal transition to mitigate age-related progression in lung cancer
  14. Paclitaxel loaded Capmul MCM and tristearin based nanostructured lipid carriers (NLCs) for glioblastoma treatment: screening of formulation components by quality by design (QbD) approach
  15. Daidzein in traditional Chinese medicine: A deep dive into its Ethnomedicinal and therapeutic applications
  16. Nanotechnology-Based Approaches for Nose-to-Brain Drug Delivery in Neurodegenerative Diseases
  17. Molecular targets and therapeutic potential of baicalein: a review
  18. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives
  19. Testing theory of mind in large language models and humans
  20. Unlocking the secrets: Volatile Organic Compounds (VOCs) and their devastating effects on lung cancer
  21. Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment
  22. Evaluation of in vitro Antioxidant and Hypoglycemic Activities of Methanol Extract of Root of Cryptolepis buchanani in Streptozotocin-induced Diabetic Rats
  23. Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases
  24. Considering the Conception of Nanotechnology Integrated on Herbal Formulation for the Management of Cancer
  25. Harnessing unexplored medicinal values of the red listed South African weed Erigeron bonariensis: From ethnobotany to biomedicine
  26. Probing the links: Long non-coding RNAs and NF-κB signalling in atherosclerosis
  27. Exploring the multifaceted potential of chlorogenic acid: Journey from nutraceutical to nanomedicine
  28. Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route
  29. Exploring ACSL4/LPCAT3/ALOX15 and SLC7A11/GPX4/NFE2L2 as Potential Targets in Ferroptosis-Based Cancer Therapy
  30. Curcumin-based Nanoformulations As an Emerging Therapeutic Strategy for Inflammatory Lung Diseases
  31. Biosimilars in Oncology: Latest Trends and Regulatory Status
  32. Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications
  33. Development and validation of RP-HPLC based bioanalytical method for simultaneous estimation of curcumin and quercetin in rat's plasma
  34. Development and validation of RP-HPLC method for 1΄-Acetoxychavicol acetate (ACA) and its application in optimizing the yield of ACA during its isolation from Alpinia galanga extract as well as its quantification in nanoemulsion
  35. Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead
  36. Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma
  37. A study of various existing interventions for the treatment of hypertension in the Indian market under the Jan Aushadhi Scheme: A price control aspect for consideration by Journal of Health Policy & Outcomes Research
  38. Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight
  39. Journey of Alpinia galanga from kitchen spice to nutraceutical to folk medicine to nanomedicine
  40. Pharmacological evaluation of Thuja occidentalis for the attenuation of nephropathy in streptozotocin-induced diabetes rats
  41. A Qualitative Evaluation of ADR Reporting in India: Non-Regulatory Confronts and Their Possible Solutions
  42. Pharmacological evaluation of Thuja occidentalis for the attenuation of neuropathy via AGEs and TNF-α inhibition in diabetic neuropathic rats
  43. Discovering multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential
  44. Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead
  45. Expanding arsenal against diabetes mellitus through nanoformulations loaded with glimepiride and simvastatin: A comparative study
  46. Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic
  47. Neuropeptides: Potential neuroprotective agents in ischemic injury
  48. Recent Progress in Development of Dressings Used for Diabetic Wounds with Special Emphasis on Scaffolds
  49. Expanding Arsenal Against Diabetes Mellitus Through Nanoformulations Loaded With Glimepiride and Simvastatin: A Comparative Study
  50. A global comparison of implementation and effectiveness of materiovigilance program: overview of regulations
  51. Demethyleneberberine: A possible treatment for Huntington’s disease
  52. Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations
  53. Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
  54. Effect of Co-Administration of Herbal Extracts with Copper Nanoparticles: A Novel Two-Pronged Approach in Treating Type 2 Diabetes
  55. Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy
  56. Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitis
  57. Cultivation, Collection and Processing of Medicinal Plants
  58. Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin
  59. Impact of solidification on micromeritic properties and dissolution rate of self-nanoemulsifying delivery system loaded with docosahexaenoic acid
  60. Salicylic acid derivatives as potential anti asthmatic agents using disease responsive drug delivery system for prophylactic therapy of allergic asthma
  61. Peritoneal Mast Cell Stabilization and Free radical Scavenging activity of Yucca gloriosa L
  62. Effect of Surgical Periodontal Therapy on Serum C-reactive Protein Levels Using ELISA in Both Chronic and Aggressive Periodontitis Patient
  63. 5-Aminosalicylic Acid attenuates allergen-induced airway inflammation and oxidative stress in asthma
  64. Assessment of inhibitory potential of Pothos scandens L. on ovalbumin-induced airway hyperresponsiveness in balb/c mice
  65. Peritoneal mast cell stabilization potential of Pothos scandens L.
  66. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma
  67. Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy